Poly(ADP-ribose) polymerase-1, DNA repair and mammalian longevity

By Burkle A.   Beneke S.   Brabeck C.   Leake A.   Meyer R.   Muiras M.-L.   Pfeiffer R.  

Experimental Gerontology, Vol. 37, Iss. 10, 2002-10 ,pp. : 1203-1205

Elsevier

Access to resources Recommend Favorite

Pharmacological Inhibition of Poly(ADP-ribose) Polymerase in Cardiovascular Disorders: Future Directions

By  

Current Vascular Pharmacology, Vol. 3, Iss. 3, 2005-07 ,pp. : 301-303

Bentham Science Publishers

Access to resources Recommend Favorite

Role for Poly(ADP-ribose) Polymerase Activation in Diabetic Nephropathy, Neuropathy and Retinopathy

By  

Current Vascular Pharmacology, Vol. 3, Iss. 3, 2005-07 ,pp. : 267-283

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative characterisation of poly(ADP-ribose) polymerase-1 from two mammalian species with different life span

By Beneke S.   Alvarez-Gonzalez R.   Burkle A.  

Experimental Gerontology, Vol. 35, Iss. 8, 2000-10 ,pp. : 989-1002

Elsevier

Access to resources Recommend Favorite

Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy

By Li F.   Szabó C.   Pacher P.   Southan G.   Abatan O.   Charniauskaya T.   Stevens M.   Obrosova I.  

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 710-717

Springer Publishing Company

Access to resources Recommend Favorite